HOME >> MEDICINE >> NEWS
New data on the effect of Atacand(R) on NYHA class in a broad spectrum of heart failure patients

Mlndal, Sweden, 9 March 2004 Data presented today at the American College of Cardiology (ACC) annual meeting add weight to the evidence shown in the original publications from the CHARM* Programme of the effects of Atacand (candesartan cilexetil) in chronic heart failure (CHF) patients. The results from further analysis of the data add further support for the CHARM study as a landmark clinical research programme.

Importantly, one analysis1 found that New York Heart Association (NYHA) functional class improved in a broad spectrum of CHF patients treated with Atacand. Of all CHARM patients, 35.4% taking Atacand improved in NYHA functional class, 55.6% remained unchanged and 9% worsened. This compared with 32.5%, 57.5% and 10.3% respectively in the placebo group (p=0.004). These findings were supported by a favourable change in the Overall Treatment Evaluation in the Atacand group compared to the placebo group (p=0.01).

Commenting on this additional analysis, Professor John McMurray, principal investigator in the CHARM-Added study, Glasgow University and Western Infirmary, Glasgow, Scotland, said "Improving symptomatic well-being is a key objective of heart failure treatment. NYHA functional classification is the most widely used and validated measure of symptomatic limitation in CHF. That candesartan has been shown to improve NYHA functional class across the broad spectrum of CHF investigated in the CHARM Programme will have significant implications for clinical practice. These findings are consistent with a reduction in CHF hospitalisations".

A further analysis suggests that the development of atrial fibrillation (AF) in some patients with symptomatic chronic heart failure may also be reduced. Of the 7,601 heart failure patients in CHARM, 72.6% did not have atrial fibrillation (AF) at baseline. This new analysis found that, in the patients randomised to Atacand, new incidence of AF during the trial was 6.5%, compared to 7.9% in the place
'"/>

Contact: Mark Chamberlain
mark.chamberlain@ketchum.com
44-207-611-3649
Ketchum
9-Mar-2004


Page: 1 2

Related medicine news :

1. Strategy effective against drug resistant tuberculosis
2. Study shows patch therapy may be as effective as oral medications
3. Chronic pain treatments more effective when taken together, new study shows
4. Geodon effective in psychiatric emergencies; Sharply reduces time in restraints
5. Brain activity prior to treatment flags vulnerability to antidepressant side effects
6. Improving access to healthy food has little effect on diet
7. Storage time and temperature effects nutrients in spinach
8. Costs of antidepressants could have funded effective alternatives
9. New ways to design safer & more effective topical (transdermal) drug delivery announced in the PNAS
10. Government wasting your taxpayer money on ineffective drug cure
11. Neurobehavioral function during coma, stroke rehabilitation effective for elderly

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/1/2020)... ... September 01, 2020 , ... Board certified ... Glendale. While the office will be the first to bear her name, Dr. ... augmentation (Brazilian butt lift), as well as rhinoplasty, facial rejuvenation, and many more ...
(Date:8/31/2020)... ... August 31, 2020 , ... Cardiothoracic surgeons ... biomedical engineers from Carnegie Mellon University (CMU) to develop a new heart monitoring ... undergone open heart surgery. , The AGH/CMU team was recently awarded a “Trailblazer” ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... management solution for chiropractors, announced today the launch of its integrated, HIPAA compliant, ... start running their virtual practice in under 90 seconds. , According to ...
(Date:8/31/2020)... , ... August 31, 2020 , ... In an effort ... Loop is donating 10 percent of each hotel room booked with a special ... of Chicagoland & Northwest Indiana (RMHC-CNI) , effective immediately. Donations will be applied ...
(Date:8/28/2020)... ... 2020 , ... WHAT , Hespiro™ is a new type ... including COVID-19, while reducing the need for scarce mechanical ventilators. It not only ... scrubs it free of carbon dioxide in a completely closed “rebreather” system, important ...
Breaking Medicine News(10 mins):
(Date:9/1/2020)... ... ... Breast and ovarian cancers are common diseases that affect many women. ... 7,500 women per year) and 10% of ovarian cancers (about 2,000 women per year) ... detectable in the Women’s Excellence Genetic Testing Program. , Dr. Jonathan Zaidan, MD, FACOG, ...
(Date:8/31/2020)... ... 31, 2020 , ... If you live in New York City you will always pay more ... it’s the law of supply and demand, but are plastic surgeons in New York worth ... of their patients that make the four-hour trip to have expert aesthetic treatments by some ...
(Date:8/28/2020)... ... 28, 2020 , ... Cano Health, LLC, a leading population ... San Antonio is happy to announce that it has selected Tejano musician Jay ... he will serve as community advisor, advertising talent, and creative consultant for Cano ...
Breaking Medicine Technology:
Cached News: